-
Vazyme Biotech Secures NMPA Nod for Two RSV Antigen Detection Kits
•
Vazyme Biotech Co., Ltd (SHA: 688105), a biotechnology company based in China, has announced that it has received marketing approval from the National Medical Products Administration (NMPA) for two of its respiratory syncytial virus (RSV) detection kits. The newly approved products include the RSV antigen detection kit utilizing the colloidal…
-
Vazyme Biotech and SPH KDL Health Join Forces to Promote Alzheimer’s Blood Tests
•
Vazyme Biotech Co., Ltd (SHA: 688105), a prominent biotech company based in China, has entered into a strategic partnership with SPH KDL Health to enhance the distribution and promotion of its Alzheimer’s disease (AD) blood test products. The collaboration may lead to the signing of a separate product agency agreement…
-
Vazyme Partners with Yufang Medical to Boost Alzheimer’s Blood Test Sales Online
•
Vazyme Biotech Co., Ltd (SHA: 688105), based in China, has entered into a strategic partnership with Shanghai Yufang Medical Technology (Group) Co., Ltd to enhance their collaboration in the screening and testing sector. Under the terms of the agreement, the two companies will leverage their respective strengths to jointly promote…
